Nymox Pharmaceutical
NYMX
#8004
Rank
$18.25 M
Marketcap
Bahamas
Country
$0.20
Share price
0.00%
Change (1 day)
-56.52%
Change (1 year)
Categories
Nymox Pharmaceutical (NYMX) - Cash on Hand
Cash on Hand as of June 2023 : $0.13 M
According to Nymox Pharmaceutical's latest financial reports the company has $0.13 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Nymox Pharmaceutical - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $1.4 M | 69.04% |
| 2021-12-31 | $0.83 M | -77.01% |
| 2020-12-31 | $3.61 M | -31.07% |
| 2019-12-31 | $5.23 M | -34.07% |
| 2018-12-31 | $7.94 M | 833.73% |
| 2017-12-31 | $0.85 M | -57.82% |
| 2016-12-31 | $2.01 M | 438.81% |
| 2015-12-31 | $0.37 M | -40.78% |
| 2014-12-31 | $0.63 M | 113.95% |
| 2013-12-31 | $0.29 M | -71.31% |
| 2012-12-31 | $1.03 M | -82.6% |
| 2011-12-31 | $5.91 M | -55.07% |
| 2010-12-31 | $13.17 M | 1870.23% |
| 2009-12-31 | $0.66 M | 142.41% |
| 2008-12-31 | $0.27 M | 1.01% |
| 2007-12-31 | $0.27 M | 16.15% |
| 2006-12-31 | $0.23 M | 55.22% |
| 2005-12-31 | $0.15 M | -71.4% |
| 2004-12-31 | $0.52 M | -12.54% |
| 2003-12-31 | $0.6 M | -8.33% |
| 2002-12-31 | $0.66 M | 35.1% |
| 2001-12-31 | $0.48 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 17,368,839.39% | 🇺🇸 USA |
 Pfizer PFE | $12.69 B | 9,613,536.36% | 🇺🇸 USA |
 Abbott Laboratories ABT | $7.27 B | 5,514,293.94% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 2,217,854.55% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $0.68 B | 519,596.97% | 🇺🇸 USA |